Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Pediatrics

Symptoms and the Path of Progression

At a Glance

Canavan disease typically presents between 3 and 6 months of age with early signs like low muscle tone, poor head control, and delayed developmental milestones. A hallmark symptom is an unusually large head size (macrocephaly), followed by progressive neurological decline.

Understanding the journey ahead with Canavan disease requires a delicate balance of honesty and hope. While the disease follows a progressive path, knowing what to expect can help you prepare and provide the most supportive environment for your child. The progression of Canavan disease is typically categorized by a transition from early “soft” signs to more complex neurological challenges [1][2].

The First Six Months: Early Indicators

In many cases, babies with Canavan disease appear to develop typically for the first few weeks of life [2]. However, between 3 and 6 months, parents and doctors often begin to notice specific physical signs:

  • Hypotonia (Weak Muscle Tone): This is often described as “floppiness” [2]. You may notice your baby feels heavy when picked up or has difficulty supporting their own weight [3].
  • Poor Head Control: Because of weakened neck muscles, the baby may be unable to hold their head steady or lift it while lying on their stomach [2].
  • Missed Milestones: Typical developmental steps, such as rolling over, reaching for toys, or sitting up without support, may be delayed or may not occur [1][4].

Understanding Macrocephaly

One of the hallmark signs of Canavan disease is macrocephaly, which is the medical term for an unusually large head size [1].

  • Why it happens: The buildup of N-acetylaspartic acid (NAA) in the brain causes fluid to accumulate and tissues to swell—a process called cytotoxic brain edema [5]. This swelling physically expands the skull [6].
  • When it appears: While it may not be present at birth, macrocephaly typically becomes noticeable within the first year of life, often by the time the child is 18 months old [1][2].
  • What it means: For doctors, an increasing head circumference combined with low muscle tone is a key diagnostic clue that points toward Canavan disease [7].

Progression and Later Symptoms

As the disease moves past the first year, the focus of care often shifts to managing more complex neurological symptoms. This progression occurs because the brain’s white matter (the insulation for nerve signals) continues to break down [8][9].

Sensory and Motor Decline

Over time, children experience a deepening of motor impairment. They may transition from low muscle tone (hypotonia) to spasticity, where the muscles become stiff and difficult to move [10]. Vision is also frequently affected. This can manifest as:

  • Nystagmus: Rapid, involuntary eye movements [7].
  • Optic Atrophy: A breakdown of the nerve that carries signals from the eye to the brain. Functionally, this means your child may have trouble tracking objects, make less eye contact, or respond less to visual stimuli over time [2][7].

Seizures and Feeding Challenges

In the later stages, typically toward the end of the first decade of life, neurological instability may increase [1].

  • Seizures: Many children develop seizures, which can sometimes be difficult to control and require specialized medications [10][11].
  • Dysphagia (Swallowing Difficulties): As the muscles used for eating weaken, swallowing becomes difficult and potentially dangerous, increasing the risk of choking or respiratory issues [1].

Emotional Awareness and Connection

While the physical decline is profound, it is crucial to know that your child’s capacity for comfort, love, and connection remains. Even as vision fades or motor skills diminish, children with Canavan disease often continue to respond to familiar voices, gentle touch, and comforting routines. Hearing often remains a strong sensory pathway. Your child is still “in there,” and finding new ways to connect—through music, cuddling, and speaking—remains a vital part of their care.

Variations in Progression

It is important to note that the “classic” timeline described above refers to the infantile form of the disease. A much smaller number of children have the mild or juvenile form [12]. These children may reach more milestones, such as walking or clear speech, and may only show milder symptoms like tremors or fine motor difficulties well into their teenage years [13][12]. Your medical team will use genetic testing and imaging to help determine which path your child’s progression is likely to follow [5].

Common questions in this guide

What are the early signs of Canavan disease in infants?
Early signs typically appear between 3 and 6 months of age. Parents may notice weak muscle tone or floppiness, poor head control, and missed milestones such as failing to roll over, reach for toys, or sit up without support.
Why do babies with Canavan disease develop a large head?
The unusually large head size, known as macrocephaly, is caused by a buildup of a chemical called NAA in the brain. This buildup causes fluid to accumulate and tissues to swell, which physically expands the baby's skull.
Will my child with Canavan disease still be able to interact with me?
While the physical decline is profound, your child's capacity for comfort, love, and connection remains. Hearing often stays a strong sensory pathway, meaning children continue to respond to familiar voices, gentle touch, and comforting routines.
Does Canavan disease always follow the same progression?
While the classic infantile form follows a progressive decline, a much smaller number of children have a mild or juvenile form. These children may reach more developmental milestones, like walking or speaking, and experience milder symptoms into their teenage years.
When should I be concerned about my child's swallowing?
As muscle weakness progresses over time, children may develop dysphagia, or difficulty swallowing. You should work with your medical team to monitor feeding safety and schedule a swallow study if eating becomes difficult to prevent choking or respiratory issues.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my child's current muscle tone and head control, what specific physical therapy exercises can we start now?
  2. 2.How often should we have my child's head circumference measured to monitor the progression of macrocephaly?
  3. 3.What are the early signs of a seizure that I should be looking for in an infant?
  4. 4.When should we schedule a formal vision assessment to check for optic atrophy or nystagmus?
  5. 5.At what point do you typically recommend a swallow study to ensure my child is feeding safely?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    The natural history of Canavan disease: 23 new cases and comparison with patients from literature.

    Bley A, Denecke J, Kohlschütter A, et al.

    Orphanet journal of rare diseases 2021; (16(1)):227 doi:10.1186/s13023-020-01659-3.

    PMID: 34011350
  2. 2

    Canavan's spongiform leukodystrophy (Aspartoacylase deficiency) with emphasis on sonographic features in infancy: description of a case report and review of the literature.

    Rossler L, Lemburg S, Weitkämper A, et al.

    Journal of ultrasound 2023; (26(4)):757-764 doi:10.1007/s40477-022-00667-2.

    PMID: 35187608
  3. 3

    Restoring Function in Pediatric Neurodegeneration: The Impact of Radio Electric Asymmetric Conveyor Neuroregenerative Treatment in a Child With Canavan Syndrome.

    Fontani V, Rinaldi A, Rinaldi S

    Cureus 2024; (16(11)):e73324 doi:10.7759/cureus.73324.

    PMID: 39524158
  4. 4

    Canavan Disease: Clinical and Laboratory Profile from Southern Part of India.

    Gowda VK, Bharathi NK, Bettaiah J, et al.

    Annals of Indian Academy of Neurology 2021; (24(3)):347-350 doi:10.4103/aian.AIAN_386_20.

    PMID: 34446995
  5. 5

    Cytotoxic edema and diffusion restriction as an early pathoradiologic marker in canavan disease: case report and review of the literature.

    Merrill ST, Nelson GR, Longo N, Bonkowsky JL

    Orphanet journal of rare diseases 2016; (11(1)):169 doi:10.1186/s13023-016-0549-1.

    PMID: 27927234
  6. 6

    Ablating the Transporter Sodium-Dependent Dicarboxylate Transporter 3 Prevents Leukodystrophy in Canavan Disease Mice.

    Wang Y, Hull V, Sternbach S, et al.

    Annals of neurology 2021; (90(5)):845-850 doi:10.1002/ana.26211.

    PMID: 34498299
  7. 7

    Homozygous Paternally Inherited ASPA Variant in a Patient with Canavan Disease.

    Yalcintepe S, Maras T, Kizilyar I, et al.

    Molecular syndromology 2024; (15(4)):284-288 doi:10.1159/000536386.

    PMID: 39119446
  8. 8

    Cellular and molecular mechanisms of aspartoacylase and its role in Canavan disease.

    Grønbæk-Thygesen M, Hartmann-Petersen R

    Cell & bioscience 2024; (14(1)):45 doi:10.1186/s13578-024-01224-6.

    PMID: 38582917
  9. 9

    Cell-Based Therapy for Canavan Disease Using Human iPSC-Derived NPCs and OPCs.

    Feng L, Chao J, Tian E, et al.

    Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2020; (7(23)):2002155 doi:10.1002/advs.202002155.

    PMID: 33304759
  10. 10

    An unusual case of a toddler with Canavan disease with frequent intractable seizures: A case report and review of the literature.

    Irilouzadian R, Goudarzi A, Hesami H, et al.

    SAGE open medical case reports 2023; (11()):2050313X231160885 doi:10.1177/2050313X231160885.

    PMID: 36968992
  11. 11

    Pathophysiology and Treatment of Canavan Disease.

    Pleasure D, Guo F, Chechneva O, et al.

    Neurochemical research 2020; (45(3)):561-565 doi:10.1007/s11064-018-2693-6.

    PMID: 30535831
  12. 12

    A case of juvenile Canavan disease with distinct pons involvement.

    Çakar NE, Aksu Uzunhan T

    Brain & development 2020; (42(2)):222-225 doi:10.1016/j.braindev.2019.11.009.

    PMID: 31839386
  13. 13

    A Mild Juvenile Onset Canavan Disease With Atypical Clinical Presentation and MRI Brain Features.

    Rehsi P, Siddiqui A, Singh R, et al.

    JIMD reports 2025; (66(4)):e70031 doi:10.1002/jmd2.70031.

    PMID: 40656657

This page provides educational information about the progression of Canavan disease. It does not replace professional medical advice, and you should always consult your pediatric neurologist regarding your child's specific symptoms and care plan.

Get notified when new evidence is published on Canavan disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.